-
Blanc M, Hsieh W, Robertson K, Watterson S, Shui G, Lacaze P, Khondoker M, Dickinson P, Sing G, Rodríguez-Martín S, Phelan P, Forster T, Strobl B, Müller M, Riemersma R, Osborne T, Wenk M, Angulo A, Ghazal P (2011) Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol 9: e1000598
doi: 10.1371/journal.pbio.1000598
-
Bordier B, Ohkanda J, Liu P, Lee S, Salazar F, Marion P, Ohashi K, Meuse L, Kay M, Casey J, Sebti S, Hamilton A, Glenn J (2003) In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Investig 112: 407–414
doi: 10.1172/JCI17704
-
Borghese F, Michiels T (2011) The leader protein of cardioviruses inhibits stress granule assembly. J Virol 85: 9614–9622
doi: 10.1128/JVI.00480-11
-
Bracht A, O'Hearn E, Fabian A, Barrette R, Sayed A (2016) Real-time reverse transcription PCR assay for detection of senecavirus a in swine vesicular diagnostic specimens. PLoS ONE 11: e0146211
doi: 10.1371/journal.pone.0146211
-
Chen Y, Wang S, Yi Z, Tian H, Aliyari R, Li Y, Chen G, Liu P, Zhong J, Chen X, Du P, Su L, Qin F, Deng H, Cheng G (2014) Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms. Sci Rep 4: 7242
-
Civra A, Cagno V, Donalisio M, Biasi F, Leonarduzzi G, Poli G, Lembo D (2014) Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci Rep 4: 7487
-
Clark P, Thompson A, Vock D, Kratz L, Tolun A, Muir A, McHutchison J, Subramanian M, Millington D, Kelley R, Patel K (2012) Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. Hepatology 56: 49–56
-
del Real G, Jiménez-Baranda S, Mira E, Lacalle R, Lucas P, Gómez-Moutón C, Alegret M, Peña J, Rodríguez-Zapata M, Alvarez-Mon M, Martínez-A C, Mañes S (2004) Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med 200: 541–547
doi: 10.1084/jem.20040061
-
Desplanques A, Nauwynck H, Vercauteren D, Geens T, Favoreel H (2008) Plasma membrane cholesterol is required for efficient pseudorabies virus entry. Virology 376: 339–345
doi: 10.1016/j.virol.2008.03.039
-
Fernández J, Agüero M, Romero L, Sánchez C, Belák S, Arias M, Sánchez-Vizcaíno J (2008) Rapid and differential diagnosis of foot-and-mouth disease, swine vesicular disease, and vesicular stomatitis by a new multiplex RT-PCR assay. J Virol Methods 147: 301–311
doi: 10.1016/j.jviromet.2007.09.010
-
Gold E, Diercks A, Podolsky I, Podyminogin R, Askovich P, Treuting P, Aderem A (2014) 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling. Proc Natl Acad Sci USA 111: 10666–10671
doi: 10.1073/pnas.1404271111
-
Hales L, Knowles N, Reddy P, Xu L, Hay C, Hallenbeck P (2008) Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus. J Gen Virol 89: 1265–1275
doi: 10.1099/vir.0.83570-0
-
Janowski B, Grogan M, Jones S, Wisely G, Kliewer S, Corey E, Mangelsdorf D (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 96: 266–271
doi: 10.1073/pnas.96.1.266
-
Kandutsch A, Chen H, Heiniger H (1978) Biological activity of some oxygenated sterols. Science 201: 498–501
doi: 10.1126/science.663671
-
Koarai A, Yanagisawa S, Sugiura H, Ichikawa T, Kikuchi T, Furukawa K, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M (2012) 25-Hydroxycholesterol enhances cytokine release and Toll-like receptor 3 response in airway epithelial cells. Respir Res 13: 63
doi: 10.1186/1465-9921-13-63
-
Leme R, Zotti E, Alcântara B, Oliveira M, Freitas L, Alfieri A, Alfieri A (2015) Senecavirus A: an emerging vesicular infection in Brazilian pig herds. Transbound Emerg Dis 62: 603–611
doi: 10.1111/tbed.12430
-
Leme R, Oliveira T, Alfieri A, Headley S, Alfieri A (2016) Pathological, immunohistochemical and molecular findings associated with senecavirus A-induced lesions in neonatal piglets. J Comp Pathol 155: 145–155
doi: 10.1016/j.jcpa.2016.06.011
-
Li C, Deng Y, Wang S, Ma F, Aliyari R, Huang X, Zhang N, Watanabe M, Dong H, Liu P, Li X, Ye Q, Tian M, Hong S, Fan J, Zhao H, Li L, Vishlaghi N, Buth J, Au C, Liu Y, Lu N, Du P, Qin F, Zhang B, Gong D, Dai X, Sun R, Novitch B, Xu Z, Qin C, Cheng G (2017) 25-Hydroxycholesterol protects host against zika virus infection and its associated microcephaly in a mouse model. Immunity 46: 446–456
doi: 10.1016/j.immuni.2017.02.012
-
Liu S, Aliyari R, Chikere K, Li G, Marsden M, Smith J, Pernet O, Guo H, Nusbaum R, Zack J, Freiberg A, Su L, Lee B, Cheng G (2013) Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38: 92–105
doi: 10.1016/j.immuni.2012.11.005
-
Lund E, Kerr T, Sakai J, Li W, Russell D (1998) cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem 273: 34316–34327
doi: 10.1074/jbc.273.51.34316
-
Lung O, Fisher M, Beeston A, Hughes K, Clavijo A, Goolia M, Pasick J, Mauro W, Deregt D (2011) Multiplex RT-PCR detection and microarray typing of vesicular disease viruses. J Virol Methods 175: 236–245
doi: 10.1016/j.jviromet.2011.05.023
-
Lv LX, Zhao GM, Wang HM, He HB (2019) Cholesterol 25-Hydroxylase inhibits bovine parainfluenza virus type 3 replication through enzyme activity-dependent and -independent ways. Vet Microbiol 239: 108456
doi: 10.1016/j.vetmic.2019.108456
-
Munger J, Bennett B, Parikh A, Feng X, McArdle J, Rabitz H, Shenk T, Rabinowitz J (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26: 1179–1186
doi: 10.1038/nbt.1500
-
Park K, Scott A (2010) Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type Ⅰ interferons. J Leukoc Biol 88: 1081–1087
doi: 10.1189/jlb.0610318
-
Qian S, Fan W, Qian P, Chen H, Li X (2016) Isolation and full-genome sequencing of Seneca Valley virus in piglets from China, 2016. Virology journal 13: 173
doi: 10.1186/s12985-016-0631-2
-
Qian S, Fan W, Liu T, Wu M, Zhang H, Cui X, Zhou Y, Hu J, Wei S, Chen H, Li X, Qian P (2017) Seneca Valley virus suppresses host type Ⅰ interferon production by targeting adaptor proteins MAVS, TRIF, and TANK for cleavage. J Virol 91: e00823-17
-
Raniga K, Liang C (2018) Interferons: reprogramming the metabolic network against viral infection. Viruses 10: 36
doi: 10.3390/v10010036
-
Reboldi A, Dang E, McDonald J, Liang G, Russell D, Cyster J (2014) Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type Ⅰ interferon. Science 345: 679–684
-
Sáiz M, De La Morena D, Blanco E, Núñez J, Fernández R, Sánchez-Vizcaíno J (2003) Detection of foot-and-mouth disease virus from culture and clinical samples by reverse transcription-PCR coupled to restriction enzyme and sequence analysis. Vet Res 34: 105–117
doi: 10.1051/vetres:2002059
-
Shibata N, Carlin A, Spann N, Saijo K, Morello C, McDonald J, Romanoski C, Maurya M, Kaikkonen M, Lam M, Crotti A, Reichart D, Fox J, Quehenberger O, Raetz C, Sullards M, Murphy R, Merrill A, Brown H, Dennis E, Fahy E, Subramaniam S, Cavener D, Spector D, Russell D, Glass C (2013) 25-Hydroxycholesterol activates the integrated stress response to reprogram transcription and translation in macrophages. J Biol Chem 288: 35812–35823
doi: 10.1074/jbc.M113.519637
-
Shrivastava-Ranjan P, Bergeron É, Chakrabarti A, Albariño C, Flint M, Nichol S, Spiropoulou C (2016) 25-Hydroxycholesterol inhibition of lassa virus infection through aberrant GP1 glycosylation. mBio 7: e01808-16
-
Venkataraman S, Reddy S, Loo J, Idamakanti N, Hallenbeck P, Reddy V (2008) Structure of Seneca Valley virus-001: an oncolytic picornavirus representing a new genus. Structure 16: 1555–1561
doi: 10.1016/j.str.2008.07.013
-
Wu T, Ma F, Ma X, Jia W, Pan E, Cheng G, Chen L, Sun C (2018) Regulating innate and adaptive immunity for controlling SIV infection by 25-hydroxycholesterol. Front Immunol 9: 2686
doi: 10.3389/fimmu.2018.02686